Article,
The Mozart effect in chronic myeloid leukaemia
Affiliations
- [1] Aarhus University Hospital [NORA names: Central Denmark Region; Hospital; Denmark; Europe, EU; Nordic; OECD]
Abstract
Clinical research has not been able to establish whether the differences between first- and second-generation BCR-ABL 1 kinase inhibitors are clinically relevant with regard to outcome. In the study by Alcazer et al., a relevant difference seems to emerge-paradoxically in the absence of the drugs-as demonstrated by differences in the relapse kinetics after cessation of therapy. Commentary on: Alcazer et al. Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients. Br J Haematol 2024;204:1536-1539.
Keywords
Mozart,
Mozart effect,
TKI cessation,
absence,
cessation,
cessation of therapy,
chronic myelogenous leukemia patients,
chronic myeloid leukemia,
clinical research,
commentary,
differences,
drugs-as,
effect,
inhibitors,
kinetics,
leukemia,
leukemia patients,
molecular recurrence,
myelogenous leukemia patients,
myeloid leukemia,
outcomes,
patients,
recurrence,
relapse,
relapse kinetics,
research,
study,
therapy,
tyrosine